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Abstract
Background: Previous evaluations have documented that studies evaluating the effectiveness of therapeutic
interventions are not always reported, and that those with statistically significant results are published more
rapidly than those without. This can lead to reporting bias in systematic reviews and other literature syntheses. We
evaluated whether diagnostic accuracy studies that report promising results about the performance of medical tests
are also published more rapidly.
Methods: We obtained all primary diagnostic accuracy studies included in meta-analyses of Medline-indexed
systematic reviews that were published between September 2011 and January 2012. For each primary study,
we extracted estimates of diagnostic accuracy (sensitivity, specificity, Youden’s index), the completion date of
participant recruitment, and the publication date. We calculated the time from completion to publication and
assessed associations with reported accuracy estimates.
Results: Forty-nine systematic reviews were identified, containing 92 meta-analyses and 924 unique primary
studies, of which 756 could be included. Study completion dates were missing for 285 (38 %) of these. Median time
from completion to publication in the remaining 471 studies was 24 months (IQR 16 to 35). Primary studies
that reported higher estimates of sensitivity (Spearman’s rho = −0.14; p = 0.003), specificity (rho = −0.17; p < 0.001), and
Youden’s index (rho = −0.22; p < 0.001) had significantly shorter times to publication. When comparing time
to publication in studies reporting accuracy estimates above versus below the median, the median number
of months was 23 versus 25 for sensitivity (p = 0.046), 22 versus 27 for specificity (p = 0.001), and 22 versus 27
for Youden’s index (p < 0.001). These differential time lags remained significant in multivariable Cox regression analyses
with adjustment for other study characteristics, with hazard ratios of publication of 1.06 (95 % CI 1.02 to 1.11; p = 0.007)
for logit-transformed estimates of sensitivity, 1.09 (95 % CI 1.04 to 1.14; p < 0.001) for logit-transformed estimates
of specificity, and 1.09 (95 % CI 1.03 to 1.14; p = 0.001) for logit-transformed estimates of Youden’s index.
Conclusions: Time to publication was significantly shorter for studies reporting higher estimates of diagnostic
accuracy compared to those reporting lower estimates. This suggests that searching and analyzing the published
literature, rather than all completed studies, can produce a biased view of the performance of medical tests.
Keywords: Reporting bias, Time lag bias, Diagnostic accuracy, Sensitivity and specificity, Research waste, Trial
registration
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Background
Many completed biomedical studies take years to get
published, if they get published at all [1, 2]. Over the
past decades, there have been increasing concerns about
the resulting bias for those relying on a synthesis of the
available literature in getting summary estimates of the
effectiveness of therapeutic interventions [3–5]. There is
now overwhelming evidence that studies with statisti-
cally non-significant results are less likely to result in a
publication in a peer-reviewed journal than those with
statistically significant results [1, 2, 6, 7]. Evaluations
have also shown that it takes more time before negative
studies are published [8–11]. There are multiple reasons
for non- or delayed publication of studies with non-
significant findings. Researchers, anticipating low scien-
tific impact, may be reluctant to write and submit the
study report; journals, foreseeing low citation rates, may
be less interested in publishing them [12, 13].
Diagnostic accuracy studies evaluate the ability of
medical tests to differentiate between patients with and
without a target condition. It is unknown whether such
studies are also susceptible to differential publication
processes, with studies that document disappointing re-
sults about a test’s performance being less likely to be
published in full, or published later, compared to studies
reporting more promising findings [14–17]. In itself,
statistical significance is unlikely to be a major determin-
ant of time to publication among diagnostic accuracy
studies; these studies typically present results only in
terms of estimates of sensitivity and specificity, and most
do not have specific hypothesis tests and accompanying
p-values [18–21]. It is possible, however, that the sheer
magnitude of the reported accuracy estimates can be
seen as a measure of the favorability of the study find-
ings, and that studies reporting higher accuracy esti-
mates are published sooner than studies reporting lower
accuracy estimates.
The objective of this study was to evaluate whether
reported accuracy estimates were associated with time
to publication among published diagnostic accuracy
studies.
Methods
Selection of diagnostic accuracy studies
We relied on a set of 114 Medline-indexed systematic
reviews of diagnostic accuracy studies, published in
English between September 2011 and January 2012.
These reviews were identified in a previous meta-
epidemiological project from our research group. The
search and selection process have been described in
full elsewhere [21].
These systematic reviews were included in the current
evaluation if they contained one or more meta-analyses
and provided 2x2 tables for the primary studies included
in these meta-analyses, describing the number of true
and false positive and negative results for the diagnostic
test under investigation. For each primary study included
in the meta-analyses we then obtained the full study re-
port or, if not available, the abstract.
Data extraction
For each primary study, two investigators (DAK, JFC)
independently extracted the test under evaluation, and
the 2x2 tables reported in the meta-analyses. These
investigators also independently identified the publica-
tion date.
For Medline-indexed studies, the date on which the
citation was added to the PubMed database was used as
the publication date. For studies not indexed in Medline,
we tried to obtain the publication date through Google
Scholar, the journal website, or the full study report. Pri-
mary studies for which no publication date could be
identified were excluded from further analysis, as were
conference abstracts.
One investigator (DAK or NvE) then extracted add-
itional data from the articles in which the primary
studies were reported. A random 10 % of this data
extraction was independently verified by the other in-
vestigator; discrepancies occurred in 3 out of 632
(0.5 %) verified characteristics.
We extracted the start date and completion date of
participant recruitment, the date of first submission to
the publishing journal, and the date the study was ac-
cepted for publication. If only the months but not the
exact dates of participant recruitment were provided,
start dates were rounded to the first day of that month,
whereas completion dates were rounded to the last day
of that month. If only years of participant recruitment
were provided, start dates were rounded to January 1st of
the starting year, and completion dates to December 31st
of the completion year.
We also extracted the journal in which the study
was published and corresponding 2014 impact factor
(through Web of Knowledge), number of authors,
country of first author, and type of data collection
(prospective/retrospective). Data extraction from study
reports published in non-English language was per-
formed with the help of native speakers, or using
Google Translate. Any disagreements in the data ex-
traction process were resolved through discussion.
Data analysis
For each included primary study, we recalculated esti-
mates of sensitivity and specificity from the extracted
2x2 tables. Because tests may have a high sensitivity but
a low specificity, or the other way around, we also calcu-
lated Youden’s index (sensitivity plus specificity minus
1). This is a single measure of diagnostic accuracy that
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takes the whole 2x2 table into account [22]. If multiple
2x2 tables were available for one primary study—which
could happen, for example, because multiple tests had
been evaluated—the highest reported estimates of sensi-
tivity, specificity and Youden’s index were used in the
analyses.
Our analysis focused on time from completion to pub-
lication, defined as the time interval between the com-
pletion date and the publication date. This was further
subdivided in time from completion to submission, and
time from submission to publication.
We calculated Spearman’s rho correlation coefficients
between accuracy estimates and time from completion
to publication; a negative correlation coefficient meaning
that studies reporting higher estimates had shorter times
to publication. To further quantify potential delays, esti-
mates of sensitivity, specificity and Youden’s index were
then dichotomized by a median split, and median times
from completion to publication were compared using
Mann–Whitney U tests. To explore more specifically in
which phase potential delays in time from completion to
publication occurred, this analysis was repeated for time
from completion to submission, and for time from sub-
mission to publication. Studies with partially missing
dates were only excluded from the analyses for that spe-
cific time interval.
We performed multivariable Cox proportional hazards
regression analysis to evaluate the unconditional and
conditional effect of accuracy estimates on the hazard of
publication, adjusting for year of publication, journal im-
pact factor (≥4 versus <4 or not available), number of
authors, continent (Europe, North America or Oceania
versus Asia, Africa or South America), type of test
(imaging versus other), type of data collection (pro-
spective versus retrospective or not reported), study
duration (time interval between the start date and
completion date), and number of participants in the
2x2 table, adding a frailty term per meta-analysis to
account for systematic differences in time to publica-
tion between meta-analyses. In this analysis, accuracy
estimates were logit transformed, where a correction
was applied for accuracy estimates of exactly 0 or 1;
these were considered to be 0.001 or 0.999. Other
continuous variables were not transformed before
adding them to the models. This analysis was also re-
peated for time from completion to submission, and
time from submission to publication.
Sensitivity analysis
We performed sensitivity analysis by excluding primary
studies that only provided the year, but not the month
or exact date of completion of participant recruitment,
as these calculations of time from completion to publi-
cation were likely to be less accurate. We also performed
sensitivity analysis by excluding studies that did not pro-
vide both a completion date and a submission date,
thereby restricting the analysis to studies for which we
had both time from completion to publication, time
from completion to submission, and time from submis-
sion to publication (complete case analysis). Data were
analyzed in SPSS v.22 and R v.3.0.3 [23, 24].
Results
Selection of diagnostic accuracy studies
Details on the selection of studies and a list of included
systematic reviews are provided in Additional files 1 and
2, respectively. In total, 49 systematic reviews could be
included in the current evaluation, containing 92 meta-
analyses. Together, these meta-analyses contained 924
unique primary diagnostic accuracy studies. Of these,
168 (18 %) had to be excluded because no publication
date could be obtained (n = 163), because they were con-
ference abstracts (n = 4), or because they had been
retracted (n = 1).
The remaining 756 primary diagnostic accuracy stud-
ies were included, corresponding to 1,088 2x2 tables, as
some studies were included in multiple meta-analyses. A
full study report could be obtained for 751 of these; for
the other 5 studies, data extraction was performed using
the abstract only.
Study characteristics
Nineteen diagnostic accuracy studies (3 %) were pub-
lished before 1990; 133 (18 %) between 1990 and 2000;
527 (70 %) between 2000 and 2010; and 77 (10 %) be-
tween 2010 and 2012. They were published in 322 differ-
ent journals, most frequently in European Journal of
Nuclear Medicine and Molecular Imaging (n = 30; 4 %),
Radiology (n = 27; 4 %), American Journal of Roentgen-
ology (n = 20; 3 %), and Journal of Clinical Microbiology
(n = 20; 3 %). The median impact factor was 3.1 (inter
quartile range [IQR] 2.0 to 5.4).
Study reports were in 10 different languages, most fre-
quently in English (n = 726; 96 %). The median number
of authors was 6 (IQR 5 to 8). First authors were from
64 different countries, most frequently USA (n = 153;
20 %), Germany (n = 60; 8 %), and Japan (n = 54; 7 %).
The type of test under investigation was an imaging
test for 387 studies (51 %) and another type of test
for 369 studies (49 %). Data collection was prospect-
ive in 307 studies (41 %), retrospective in 125 studies
(17 %), and not reported in 324 studies (43 %). The
median study duration was 22 months (IQR 12 to 37),
with a median number of participants of 100 (IQR 49 to
255). The median accuracy estimates were 0.875 (IQR
0.73–0.97) for sensitivity, 0.899 (0.76–0.97) for specificity,
and 0.684 (0.45–0.83) for Youden’s index.
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Time to publication: association with reported estimates
of diagnostic accuracy
Of the included primary studies, 520 (69 %) reported
a submission date, 564 (75 %) an acceptance date,
474 (63 %) a start date, and 471 (62 %) a completion
date. Median times between study stages are summa-
rized in Fig. 1.
The median time from completion to publication (avail-
able for 471 studies) was 24 months (IQR 16 to 35). Sensi-
tivity (rho = −0.14; p = 0.003), specificity (rho = −0.17;
p < 0.001), and Youden’s index (rho = −0.22; p < 0.001)
were each negatively correlated with time from com-
pletion to publication (Fig. 2).
When comparing time from completion to publication
in studies reporting accuracy estimates above versus
below the median, the median number of months was
23 versus 25 for sensitivity (p = 0.046), 22 versus 27 for
specificity (p = 0.001), and 22 versus 27 for Youden’s
index (p < 0.001) (Table 1; Fig. 3). Median time from
completion to publication stratified by other categories
of study characteristics is provided in Table 2.
These differential time lags remained significant in
multivariable Cox regression analyses, with hazard ratios
of publication of 1.06 (95 % confidence interval [CI] 1.02
to 1.11; p = 0.007) for logit-transformed estimates of sen-
sitivity, 1.09 (95 % CI 1.04 to 1.14; p < 0.001) for logit-
transformed estimates of specificity, and 1.09 (95 % CI
1.03 to 1.14; p = 0.001) for logit-transformed estimates of
Youden’s index (Table 3).
When subdividing time from completion to publication,
we observed significant associations between accuracy es-
timates and time from completion to submission (avail-
able for 330 studies), but not between accuracy estimates
and time from submission to publication (available for
520 studies) (Table 1, with multivariable Cox regression
analyses in Additional files 3 and 4).
Sensitivity analysis
The sign and significance of the association between es-
timates of diagnostic accuracy and time from completion
to publication, time from completion to submission, and
time from submission to publication remained the same
when excluding studies that only reported the year of
completion of participant recruitment but not the
month or exact date, and when excluding studies that
did not report both a completion date and a submission
date (Additional file 5).
Discussion
In a large sample of published diagnostic accuracy
studies, we found that it took authors on average two
years to publish study findings after completing par-
ticipant recruitment. Time from completion to publi-
cation was significantly shorter for studies reporting
higher estimates of diagnostic accuracy compared to
those reporting lower estimates, a delay that could
not be attributed to differences in speed of processing
within the journals that eventually published the studies.
Some elements deserve consideration. Many reports of
diagnostic accuracy studies contain multiple accuracy
outcomes, for example, for different tests, target condi-
tions, and subgroups. We only obtained the 2x2 tables
that were used in the selected meta-analyses, but the pri-
mary studies may have focused on other accuracy out-
comes as well. Whenever a study reported multiple 2x2
tables, we selected the highest accuracy estimates in our
analysis, because in our personal experience authors
have a tendency to emphasize these in their conclusions.
However, whether the highest accuracy estimates in a
study are indeed the ones that drive time to publication
is unknown. In our analysis, we focused on dichoto-
mized accuracy estimates, as this allowed us to provide a
straightforward quantification of the delays that can be
anticipated in the publication of results that are rela-
tively disappointing in diagnostic research. We acknow-
ledge that a dichotomization in terms of a median-split
is arbitrary, and that this may not reflect the difference
between statistically significant and non-significant re-
sults based on the p-value.
Although the STAndards for Reporting Diagnostic ac-
curacy (STARD) statement invites authors to report start
and completion dates of participant recruitment [25],
these were not provided by more than one-third of the
studies. As a consequence, we could not include these
studies in our analyses of time from completion to pub-
lication. This obviously limited the precision of our find-
ings, but we do not know whether the included sample
is a biased one. We included eight additional variables in
our Cox regression analyses. It is conceivable that there
are other unmeasured confounders in the association be-
tween accuracy estimates and time to publication as
well. Especially several study characteristics that are as-
sociated with study quality and risk of bias, such as
blinding of test readers and quality of the reference
standard, may be relevant in this respect. We did not in-
clude these elements because they are often not
Fig. 1 Median times between study stages. Median times missing for: a246; b426; c275; and d192 of 756 included studies
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Fig. 2 Correlations between reported estimates of diagnostic accuracy and time from completion to publication. a Sensitivity. b Specificity.
c Youden’s index. Each dot represents one diagnostic accuracy study
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reported, and the extent to which they induce bias varies
substantially depending on the type of test under investi-
gation and the clinical area in which the test is applied
[26, 27]. However, we believe that excluding these is more
likely to have led to under- rather than overestimations of
the associations identified in this study: poor study quality
generally leads to inflated accuracy estimates, but will
probably also increase time to publication as a result of
critical peer-reviewers and more journal rejections.
Several previous evaluations found a comparable dif-
ferential time lag among studies of therapeutic inter-
ventions. A Cochrane review that aimed to document
the association between statistically significant results
and time to publication included two of such evalua-
tions, together analyzing the fate of 196 initiated clin-
ical trials [8–10]. On average, trials with significant
results were published about 2 to 3 years earlier than
those with non-significant results. In a similar, more re-
cent evaluation of 785 initiated clinical trials, the
estimated median time from completion to publication
was 2.1 years for those with significant results, and
3.2 years for those that with non-significant ones [11].
A differential time lag was not identified in another
evaluation of 1,336 published clinical trials: both those
with significant and non-significant outcomes had a
median time to publication of 21 months [28].
Similar evaluations are scarce for diagnostic accur-
acy studies, and so far limited to abstracts presented
at scientific conferences in specific fields of research.
In contrast to our findings, no systematic bias could
be identified in these previous assessments. One study
found a median time from presentation to full publi-
cation of 16 months for 160 conference abstracts of
diagnostic accuracy studies in stroke research, but the
hazard of full publication was not associated with re-
ported estimates of Youden’s index [15]. We recently
found that the median time from presentation to
publication was 17 months among 399 conference
Table 1 Time to publication: association with dichotomized accuracy estimates














Overall 471 (100 %) 24 (16–35) 330 (100 %) 14 (7–25) 520 (100 %) 238 (177–329)
Sensitivityd
<0.875 226 (48 %) 25 (16–39) 0.046 149 (45 %) 16 (7–30) 0.037 225 (43 %) 240 (176–324) 0.755
≥0.875 239 (51 %) 23 (15–32) 179 (54 %) 13 (7–22) 293 (56 %) 238 (183–335)
Specificitye
<0.899 209 (44 %) 27 (18–38) 0.001 152 (46 %) 17 (9–30) 0.001 262 (50 %) 238 (176–317) 0.494
≥0.899 250 (53 %) 22 (15–31) 173 (52 %) 12 (6–22) 252 (48 %) 238 (180–332)
Youden’s indexf
<0.684 225 (48 %) 27 (18–39) <0.001 157 (48 %) 17 (10–30) <0.001 245 (47 %) 235 (176–321) 0.251
≥0.684 230 (49 %) 22 (14–31) 166 (50 %) 11 (6–21) 267 (51 %) 244 (180–332)
Median times missing for: a285, b426, and c236 of 756 included studies
dSensitivity, eSpecificity, and fYouden’s index missing for 7, 14 and 18 of 756 included studies, respectively
Fig. 3 Time from completion to publication. a Sensitivity. b Specificity. c Youden’s index
Korevaar et al. BMC Medical Research Methodology  (2016) 16:68 Page 6 of 10
abstracts of diagnostic accuracy studies in ophthalmology
research; there also, the hazard of publication was not as-
sociated with reported estimates of sensitivity and specifi-
city (manuscript submitted for publication).
In the current evaluation, on average, it took two
months less to publish studies with a sensitivity above
the median, five months less to publish studies with a
specificity above the median, and five months less to
publish studies with a Youden’s index above the median,
compared to studies reporting estimates of these accur-
acy estimates below the median. Although these time
lags can be considered as relatively minor, the potential
implications, although difficult to overlook, may be wor-
risome for multiple reasons.
We believe that the observed differential time lag may
reflect a larger underlying problem. A study’s chances to
reach full publication are likely to fade over time and
with every rejection by a journal. This may lead to fail-
ure to publish the study and, consequently, to publica-
tion bias, since the study will be missing from the
evidence base to those relying on databases of published
articles [3]. Although there is strong evidence of such
bias in syntheses of studies of therapeutic interventions,
this topic has been insufficiently investigated for diag-
nostic accuracy studies [14–17].
Even if studies with less favorable results are even-
tually published, a delay in their publication and asso-
ciated dissemination can lead to misleading results in
systematic reviews. Reporting bias may occur when
literature reviewers want to synthesize the available
evidence but cannot account for unfavorable results
that take substantially longer to get published [8]. To
assess time trends in published accuracy estimates, we
recently applied cumulative meta-analysis to the same
set of systematic reviews as used in the current evalu-
ation [29]. Among 48 meta-analyses included, a total
of 12 statistically significant time trends in sensitivity
or specificity were identified. The majority of these
time trends, 8 out of 12 (67 %), were negative, which
may indicate that studies that are published earlier
sometimes tend to overestimate the accuracy of a test.
This may be partially explained by a time lag in the
publication of studies that report lower accuracy esti-
mates, as identified in the current evaluation.
The delay in publishing studies with lower accuracy
estimates could be attributed to study authors, who may
be less motivated to write and submit corresponding
study reports, to peer reviewers, who may be more crit-
ical towards and less supportive of studies with unfavor-
able results, or to journal editors, who may be less
willing to publish studies reporting disappointing per-
formance of new and existing tests [12, 13]. In our
evaluation, we did observe a differential time lag from
study completion to submission, but not from submis-
sion to publication, indicating that delayed publication
of studies with lower accuracy estimates was not caused
by the journal that eventually published the study report.
This suggests two alternative explanations for the delay.
Table 2 Time from completion to publication: association with
other study characteristics
Studies n (%) Months Median (IQR)
Overalla 471 (100 %) 24 (16–35)
Year of publication
<1990 10 (2 %) 26 (17–53)
1990–1994 15 (3 %) 18 (14–38)
1995–1999 44 (9 %) 23 (15–36)
2000–2004 99 (21 %) 26 (18–37)
2005–2009 243 (52 %) 23 (16–35)
≥2010 60 (13 %) 22 (15–35)
Journal impact factor
<4 or not available 312 (66 %) 25 (16–37)
4–9 129 (27 %) 22 (15–33)
≥10 30 (6 %) 22 (16–34)
Number of authors
<6 170 (36 %) 23 (14–38)
≥6 301 (64 %) 24 (17–34)
Continent of first author
Africa 32 (7 %) 31 (20–48)
Asia 125 (27 %) 20 (13–29)
Europe 183 (39 %) 24 (17–35)
North America 116 (25 %) 26 (16–39)
Oceania 10 (2 %) 28 (21–44)
South America 5 (1 %) 19 (14–50)
Type of test
Imaging 229 (49 %) 24 (16–34)
Other 242 (51 %) 24 (16–37)
Type of data collection
Prospective 192 (41 %) 24 (17–34)
Retrospective 96 (20 %) 25 (15–36)
Not reported 183 (39 %) 24 (15–38)
Study durationb
<13 months 115 (24 %) 24 (15–34)
13–24 months 139 (30 %) 25 (19–35)
≥25 months 216 (46 %) 24 (14–37)
Number of participants
<100 208 (44 %) 24 (15–35)
100–999 232 (49 %) 24 (16–35)
≥1000 31 (7 %) 27 (20–39)
aTime from completion to publication missing for 285 of 756 included studies
bStudy duration missing for 1 of 471 studies included in this analysis
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One is that authors were less effective, maybe even re-
luctant, in finalizing and submitting their study report.
Another explanation is that the manuscript was not ac-
cepted by the journals where authors initially submitted
the report to, and this could have been caused, in part,
by the less positive findings.
In the multivariable Cox regression analysis for
Youden’s index, two additional variables were also sig-
nificantly associated with time from completion to
publication. Studies published in journals with a
higher impact factor were published more rapidly. An
explanation could be that authors first submit their
study to higher impact factor journals, going down
after each rejection, which would then delay publica-
tion. When pooling studies from Africa, Asia and
South America, these were published more rapidly
than those from Europe, North America and Oceania.
Little is known about geographical differences in
quality and rigorousness of the editorial and peer-
review processes of biomedical journals.
The findings of this study are relevant for scholars that
want to arrive at a synthesis of the available evidence
through a search of the literature, and for patients, clini-
cians, policy makers and funders, that may rely on these
literature syntheses. They should be fully aware that it is
very well possible that not all completed diagnostic ac-
curacy studies have been published at the time of the
evaluation, and that this could introduce reporting bias.
Such bias is likely to be more pronounced if only few
published studies are available. As recommended in
current guidelines [17], additional efforts should be
made to identify and include unpublished studies in sys-
tematic reviews, as this will strengthen the validity and
improve the precision and applicability of the results.
Table 3 Time from completion to publication: multivariable Cox
regression analyses
Hazard ratio (95 % CI)a p-value
Model 1: Sensitivity (n = 464)
Sensitivity (logit transformed) 1.06 (1.02–1.11) 0.007
Year of publication (per 5 years) 0.98 (0.88–1.08) 0.660
Journal impact factor
≥4 1.24 (0.99–1.55) 0.064
<4 or not available 1
Number of authors 0.99 (0.96–1.02) 0.550
Continent of first author
Europe, North America or Oceania 0.69 (0.55–0.87) 0.002
Africa, Asia or South America 1
Type of test
Imaging 1.15 (0.88–1.50) 0.300
Other 1
Type of data collection
Prospective 1.19 (0.96–1.48) 0.120
Retrospective or not reported 1
Study duration (per year)b 1.00 (0.98–1.03) 0.820
Number of participants (per 1000) 1.01 (0.99–1.03) 0.430
Model 2: Specificity (n = 458)
Specificity (logit transformed) 1.09 (1.04–1.14) <0.001
Year of publication (per 5 years) 1.01 (0.91–1.11) 0.910
Journal impact factor
≥4 1.34 (1.07–1.67) 0.011
<4 or not available 1
Number of authors 0.99 (0.96–1.02) 0.360
Continent of first author
Europe, North America or Oceania 0.72 (0.57–0.90) 0.003
Africa, Asia or South America 1
Type of test
Imaging 1.15 (0.90–1.46) 0.260
Other 1
Type of data collection
Prospective 1.23 (1.00–1.52) 0.050
Retrospective or not reported 1
Study duration (per year)b 1.00 (0.98–1.02) 0.980
Number of participants (per 1000) 1.01 (0.99–1.03) 0.540
Model 3: Youden’s index (n = 454)
Youden’s index (logit transformed)g 1.09 (1.03–1.14) 0.001
Year of publication (per 5 years) 0.98 (0.89–1.09) 0.730
Journal impact factor
≥4 1.28 (1.02–1.61) 0.031
<4 or not available 1
Number of authors 0.98 (0.95–1.01) 0.280
Table 3 Time from completion to publication: multivariable Cox
regression analyses (Continued)
Continent of first author
Europe, North America or Oceania 0.69 (0.55–0.87) 0.002
Africa, Asia or South America 1
Type of test
Imaging 1.16 (0.90–1.51) 0.250
Other 1
Type of data collection
Prospective 1.24 (1.00–1.54) 0.052
Retrospective or not reported 1
Study duration (per year)b 1.00 (0.98–1.02) 0.910
Number of participants (per 1000) 1.01 (0.99–1.03) 0.460
aFrailty term added per meta-analysis to account for systematic differences in
time from completion to publication between meta-analyses; variance of frailty
terms was: model 1 = 0.103; model 2 = 0.064; model 3 = 0.094
bOne study was excluded from the Cox regression analysis because of a
missing study duration
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Concerns about reporting bias were one factor that
prompted the implementation of trial registration policies
[30]. The International Committee of Journal Editors now
only considers trials for publication if they were registered
in a publically accessible trial registry before study start
[31]. Unfortunately, currently only 15 % of published diag-
nostic accuracy studies are being registered [32]. Over the
past years, evidence that many diagnostic accuracy studies
remain unpublished has accumulated [14–17], making a
strong case for a firmer implementation of registration
policies for these studies [33–36]. The fact that the
current evaluation suggests that there may also be bias in
the process of publishing diagnostic accuracy studies fur-
ther amplifies this message.
Registration of diagnostic accuracy studies would enable
the identification of all relevant studies in a timely manner,
not only those that have been published. Funders, govern-
mental organizations and academic institutions could also
require the publication of results within a year after study
completion, as currently required by the Food and Drug
Administration (FDA) for certain trials [37]. In an era of
transparency and open access, stakeholders involved in
biomedical research should make efforts to ensure that
study results become available in a timely manner; this
should apply to all studies, not just those presenting
promising, optimistic and fascinating results [5, 38].
Conclusions
Time to publication was significantly shorter for studies
reporting higher estimates of diagnostic accuracy com-
pared to those reporting lower estimates. This suggests
that searching the published literature, rather than all
completed studies, can produce a biased view of the per-
formance of medical tests.
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